Nuclear Medicine Radiopharmaceuticals Market Share 2021: Global Trends, Key Players, Industry Analysis Report to 2027

The Nuclear Medicine Radiopharmaceuticals Market size is expected to grow at an annual average of 3% during 2021-2027. Radiopharmaceuticals are pharmaceutical preparations containing radioactive isotopes used for diagnosis and treatment. Simple, small substances containing radioactive substances used to treat cancer and heart and nerve disorders.

The following segmentation are covered in this report:

By Application

• Oncology
• Cardiology
• Neurology
• Thyroid 
• Others

By End-user

• Hospitals and diagnostic centers
• Research institutes

By Procedures

• Oncology 
• Cardiovascular 
• Central Nervous System 
• Endocrine 
• Skeletal 
• Gastrointestinal 
• Genito-urinary 
• Pulmonary 
• PET & PET-CT 
• Therapeutic 
• Others

Company Profile

• Curium Pharma (France)
• Bayer Group (Germany)
• GE Healthcare (U.S.)
• Cardinal Health (U.S.)
• Jubilant Life science (India)
• Lantheus Medical Imaging (U.S.)
• Novartis International AG (Advanced accelerator) (Switzerland)
• South African Nuclear Energy Corporation (NTP Radioisotopes SOC Ltd) (South Africa)
• Fujifilm Holding Corporation (Japan)

Scope of the report

The research study analyses the Nuclear Medicine Radiopharmaceuticals Market industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent developments

• Market overview and growth analysis
• Import and export overview
• Volume analysis
• Current market trends and future outlook
• Market opportunistic and attractive investment segment

Geographic coverage

• North america market size and/or volume
• Latin america market size and/or volume
• Europe market size and/or volume
• Asia-pacific market size and/or volume
• Rest of the world market size and/or volume

Key Questions Answered by Nuclear Medicine Radiopharmaceuticals Market Report

• What was the Nuclear Medicine Radiopharmaceuticals Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2021-2027)
• What will be the CAGR of Market during the forecast period (2021-2027)?
• Which segments (product type/applications/end-user) were most attractive for investments in 2021? How these segments are expected to grow during the forecast period (2021-2027).
• Which manufacturer/vendor/players in the Nuclear Medicine Radiopharmaceuticals Market was the market leader in 2020?
• Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.